Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy™ Series - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates held virtually on February 10, 2022 are available here.
Program Organizers
Program Summary
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for a variety of topics from leaders in this specific field. The ACI program also featured a discussion of closed cases submitted from attendees to hear guidance and insights from expert faculty.
Program Learning Objectives
Please note on-demand recordings are not available for continuing education credits.#AdvancesinCancerImmunotherapy(ACI)#2022#MonoclonalAntibodies#AntibodyDrugConjugates#PresentationSlides#Video
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aditya Bardia, MD, MPH – Massachusetts General Hospital; Patrick A. Brown, MD – Johns Hopkins University; Christian M. Capitini, MD – University of Wisconsin-Madison; David Ilson, MD, PhD – Memorial Sloan Kettering Cancer Center; Hope S. Rugo, MD – University of California San Francisco Comprehensive Care Center; February 10, 2022;00:46:15
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aaron Logan, MD, PhD - University of California San Francisco; Date: February 10, 2022;00:41:24
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Komal Jhaveri, MD, FACP - Memorial Sloan Kettering Cancer Center; February 10, 2022;00:40:54
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Aditya Bardia, MD, MPH - Massachusetts General Hospital; February 10, 2022;00:25:58
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Patrick A. Brown, MD - John Hopkins University; Date: February 10, 2022;00:27:17
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: Daniel P. Petrylak, MD- Yale School of Medicine; Date: February 10, 2022;00:19:22
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on Monoclonal Antibodies and Antibody Drug Conjugates; Presenter: David Ilson, MD, PhD - Memorial Sloan Kettering Cancer Center; Date: February 10, 2022;00:23:00
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us